Enrico Franceschi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 47

Top Topics

Brain Metastases

Top Venues

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Angelo Dipasquale, Enrico Franceschi, Giuseppe Lombardi, Matteo Simonelli
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence? Neuro-oncology advances 6 (1) (2024)
Vincenzo Di Nunno, Marta Aprile, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Stefania Bartolini, Enrico Franceschi
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. CNS oncology 13 (1) (2024)
Vincenzo Di Nunno, Lidia Gatto, Marta Aprile, Stefania Bartolini, Alicia Tosoni, Enrico Franceschi
Economic income and survival in patients affected by glioblastoma: A systematic review and meta-analysis. Neuro-oncology practice 11 (5) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Angelo Dipasquale, Enrico Franceschi, Giuseppe Lombardi, Matteo Simonelli
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence? Neuro-oncology advances 6 (1) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Martin J Van Den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. Neuro-oncology 26 (Supplement_2) (2024)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Vincenzo Di Nunno, Alicia Tosoni, Stefania Bartolini, Lucia Ranieri, Enrico Franceschi
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open. Cancers 15 (12) (2023)
Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Enrico Franceschi
Letter concerning "Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival": Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma. Neuro-oncology (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Martin van den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi
H3 K27M-altered Glioma and Diffuse Intrinsic Pontine Glioma: Semi-systematic Review of Treatment Landscape and Future Directions. Neuro-oncology (2023)
Vincenzo Di Nunno, Marta Aprile, Stefania Bartolini, Lidia Gatto, Alicia Tosoni, Lucia Ranieri, Dario de Biase, Sofia Asioli, Enrico Franceschi
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? Cells 13 (1) (2023)
Lidia Gatto, Vincenzo Di Nunno, Alicia Tosoni, Stefania Bartolini, Lucia Ranieri, Enrico Franceschi
DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open. Cancers 15 (12) (2023)
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi, Alba Ariela Brandes
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem. Expert review of anticancer therapy 21 (12) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology 16 (1) (2022)
Vincenzo Di Nunno, Mario Fordellone, Giuseppe Minniti, Sofia Asioli, Alfredo Conti, Diego Mazzatenta, Damiano Balestrini, Paolo Chiodini, Raffaele Agati, Caterina Tonon, Alicia Tosoni, Lidia Gatto, Stefania Bartolini, Raffaele Lodi, Enrico Franceschi
Machine learning in neuro-oncology: toward novel development fields. Journal of neuro-oncology 159 (2) (2022)
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date? Drugs 82 (5) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology 16 (1) (2022)
Enrico Franceschi, Caterina Giannini, Julia Furtner, Kristian W Pajtler, Sofia Asioli, Raphael Guzman, Clemens Seidel, Lidia Gatto, Peter Hau
Adult Medulloblastoma: Updates on Current Management and Future Perspectives. Cancers 14 (15) (2022)
Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer, Hafida Lmalem, Dieta Brandsma, Priya U Kumthekar, Antonella Castellano, Annette Compter, Frederic Dhermain, Enrico Franceschi, Peter Forsyth, Julia Furtner, Norbert Galldiks, Jaime Gállego Pérez-Larraya, Jens Gempt, Elke Hattingen, Johann Martin Hempel, Slavka Lukacova, Giuseppe Minniti, Barbara O'Brien, Tjeerd J Postma, Patrick Roth, Roberta Rudà, Niklas Schaefer, Nils O Schmidt, Tom Jan Snijders, Steffi Thust, Martin van den Bent, Anouk van der Hoorn, Guillaume Vogin, Marion Smits, Joerg C Tonn, Kurt A Jaeckle, Matthias Preusser, Michael Glantz, Patrick Y Wen, Martin Bendszus, Michael Weller
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro-oncology 24 (10) (2022)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Raffaele Lodi, Raffaele Agati, Stefania Bartolini, Alba Ariela Brandes
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology. Biomedicines 10 (12) (2022)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Raffaele Lodi, Raffaele Agati, Stefania Bartolini, Alba Ariela Brandes
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology. Biomedicines 10 (12) (2022)
Deborah Malvi, Francesco Vasuri, Thais Maloberti, Viviana Sanza, Antonio De Leo, Adele Fornelli, Michele Masetti, Claudia Benini, Raffaele Lombardi, Maria Fortuna Offi, Mariacristina Di Marco, Matteo Ravaioli, Sirio Fiorino, Enrico Franceschi, Alba A Brandes, Elio Jovine, Antonietta D'Errico, Giovanni Tallini, Dario de Biase
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream? Immunotherapy 14 (10) (2022)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments. Expert review of clinical pharmacology (2022)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi, Alba Ariela Brandes
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment. Molecular diagnosis & therapy 25 (4) (2021)
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alba Ariela Brandes
BET inhibitors: the promise of a new generation of immunotherapy in glioblastoma. Immunotherapy (2021)
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Alba Ariela Brandes
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light. Expert review of anticancer therapy 21 (11) (2021)
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Daniele Angelini, Stefania Bartolini, Raffaele Lodi, Alba Ariela Brandes
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets. Diagnostics (Basel, Switzerland) 11 (10) (2021)
Peter Hau, Didier Frappaz, Elizabeth Hovey, Martin G McCabe, Kristian W Pajtler, Benedikt Wiestler, Clemens Seidel, Stephanie E Combs, Linda Dirven, Martin Klein, Antoinette C Anazodo, Elke Hattingen, Silvia Hofer, Stefan M Pfister, Claus Zimmer, Rolf-Dieter Kortmann, Marie-Pierre Sunyach, Ronan Tanguy, Rachel Effeney, Andreas von Deimling, Felix Sahm, Stefan Rutkowski, Anna S Berghoff, Enrico Franceschi, Estela Pineda Losada, Dagmar Beier, Ellen Peeters, Thierry Gorlia, Maureen Vanlancker, Jacoline E C Bromberg, Julien Gautier, David S Ziegler, Matthias Preusser, Wolfgang Wick, Michael Weller
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23. Cancers 13 (14) (2021)
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Ilaria Maggio, Raffaele Lodi, Daniele Angelini, Stefania Bartolini, Alba Ariela Brandes
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. Advances in therapy (2021)
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Ilaria Maggio, Caterina Tonon, Raffaele Lodi, Raffaele Agati, Stefania Bartolini, Alba Ariela Brandes
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review. Clinical case reports 9 (8) (2021)
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alba Ariela Brandes
Chimeric antigen receptor macrophage for glioblastoma immunotherapy: the way forward. Immunotherapy 13 (11) (2021)
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi, Alba Ariela Brandes
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS oncology 10 (2) (2021)
Vincenzo Di Nunno, Giacomo Nuvola, Mirta Mosca, Ilaria Maggio, Lidia Gatto, Alicia Tosoni, Raffaele Lodi, Enrico Franceschi, Alba Ariela Brandes
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases. Immunotherapy 13 (5) (2021)
Enrico Franceschi, Santino Minichillo, Alicia Tosoni, Maurizio Mascarin, Antonella Mura, Monica Di Battista, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study. Tumori (2021)
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes
Glioblastoma: Emerging Treatments and Novel Trial Designs. Cancers 13 (15) (2021)
Michela Visani, Gianluca Marucci, Dario de Biase, Felice Giangaspero, Francesca Romana Buttarelli, Alba Ariela Brandes, Enrico Franceschi, Giorgia Acquaviva, Alessia Ciarrocchi, Kerry Jane Rhoden, Giovanni Tallini, Annalisa Pession
Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10, 265. Diagnostics (Basel, Switzerland) 11 (9) (2021)
Enrico Franceschi, Alba Ariela Brandes
Burnout in medical oncology during the COVID-19 pandemic. Expert review of anticancer therapy 21 (4) (2020)
Alba Ariela Brandes, Andrea Ardizzoni, Fabrizio Artioli, Federico Cappuzzo, Luigi Cavanna, Giovanni Luca Frassineti, Antonio Frassoldati, Francesco Leonardi, Giuseppe Longo, Antonio Maestri, Davide Tassinari, Enrico Franceschi, Vincenzo Di Nunno, Carmine Pinto
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy. Future oncology (London, England) 16 (20) (2020)
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Monica Di Battista, Lidia Gatto, Cinzia Lamperini, Santino Minichillo, Antonella Mura, Stefania Bartolini, Alba Ariela Brandes
Treatment of recurrent glioblastoma: state-of-the-art and future perspectives. Expert review of anticancer therapy 20 (9) (2020)